High-Value, Cost-Conscious Health Care: Concepts for Clinicians to Evaluate the Benefits, Harms, and Costs of Medical Interventions

被引:250
作者
Owens, Douglas K.
Qaseem, Amir [1 ]
Chou, Roger
Shekelle, Paul
机构
[1] Amer Coll Physicians, Philadelphia, PA 19106 USA
关键词
LOW-BACK-PAIN; AMERICAN-COLLEGE; PRACTICE GUIDELINES; GRADING QUALITY; UNITED-STATES; HIV; AHRQ; STRENGTH; LIFE; RECOMMENDATIONS;
D O I
10.7326/0003-4819-154-3-201102010-00007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Health care costs in the United States are increasing unsustainably, and further efforts to control costs are inevitable and essential. Efforts to control expenditures should focus on the value, in addition to the costs, of health care interventions. Whether an intervention provides high value depends on assessing whether its health benefits justify its costs. High-cost interventions may provide good value because they are highly beneficial; conversely, low-cost interventions may have little or no value if they provide little benefit. Thus, the challenge becomes determining how to slow the rate of increase in costs while preserving high-value, high-quality care. A first step is to decrease or eliminate care that provides no benefit and may even be harmful. A second step is to provide medical interventions that provide good value: medical benefits that are commensurate with their costs. This article discusses 3 key concepts for understanding how to assess the value of health care interventions. First, assessing the benefits, harms, and costs of an intervention is essential to understand whether it provides good value. Second, assessing the cost of an intervention should include not only the cost of the intervention itself but also any downstream costs that occur because the intervention was performed. Third, the incremental cost-effectiveness ratio estimates the additional cost required to obtain additional health benefits and provides a key measure of the value of a health care intervention.
引用
收藏
页码:174 / +
页数:8
相关论文
共 49 条
[1]  
[Anonymous], GUID METH TECHN APPR
[2]  
[Anonymous], 1996, COST EFFECTIVENESS H, DOI DOI 10.1093/OSO/9780195108248.001.0001
[3]   Cost-effectiveness of HIV monitoring strategies in resource-limited settings - A Southern African analysis [J].
Bendavid, Eran ;
Young, Sean D. ;
Katzenstein, David A. ;
Bayoumi, Ahmed M. ;
Sanders, Gillian D. ;
Owens, Douglas K. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (17) :1910-1918
[4]   Optimal medical therapy with or without PCI for stable coronary disease [J].
Boden, William E. ;
O'Rourke, Robert A. ;
Teo, Koon K. ;
Hartigan, Pamela M. ;
Maron, David J. ;
Kostuk, William J. ;
Knudtson, Merril ;
Dada, Marcin ;
Casperson, Paul ;
Harris, Crystal L. ;
Chaitman, Bernard R. ;
Shaw, Leslee ;
Gosselin, Gilbert ;
Nawaz, Shah ;
Title, Lawrence M. ;
Gau, Gerald ;
Blaustein, Alvin S. ;
Booth, David C. ;
Bates, Eric R. ;
Spertus, John A. ;
Berman, Daniel S. ;
Mancini, G. B. John ;
Weintraub, William S. ;
Boden, W. ;
O'Rourke, R. ;
Teo, K. ;
Hartigan, P. ;
Weintraub, W. ;
Maron, D. ;
Mancini, J. ;
Weintraub, W. ;
Boden, W. ;
O'Rourke, R. ;
Teo, K. ;
Hartigan, P. ;
Knudtson, M. ;
Maron, D. ;
Bates, E. ;
Blaustein, A. ;
Booth, D. ;
Carere, R. ;
Ellis, S. ;
Gosselin, G. ;
Gau, G. ;
Jacobs, A. ;
King, S., III ;
Kostuk, W. ;
Harris, C. ;
Spertus, J. ;
Peduzzi, P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (15) :1503-1516
[5]   What does the value of modern medicine say about the $50,000 per Quality-Adjusted Life-Year decision rule? [J].
Braithwaite, R. Scott ;
Meltzer, David O. ;
King, Joseph T., Jr. ;
Leslie, Douglas ;
Roberts, Mark S. .
MEDICAL CARE, 2008, 46 (04) :349-356
[6]   Systematic review: The comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery [J].
Bravata, Dena M. ;
Gienger, Allison L. ;
McDonald, Kathryn M. ;
Sundaram, Vandana ;
Perez, Marco V. ;
Varghese, Robin ;
Kapoor, John R. ;
Ardehali, Reza ;
Owens, Douglas K. ;
Hlatky, Mark A. .
ANNALS OF INTERNAL MEDICINE, 2007, 147 (10) :703-U139
[7]   Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing [J].
Brown, AD ;
Garber, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (04) :347-353
[8]   Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies [J].
Brozek, J. L. ;
Akl, E. A. ;
Jaeschke, R. ;
Lang, D. M. ;
Bossuyt, P. ;
Glasziou, P. ;
Helfand, M. ;
Ueffing, E. ;
Alonso-Coello, P. ;
Meerpohl, J. ;
Phillips, B. ;
Horvath, A. R. ;
Bousquet, J. ;
Guyatt, G. H. ;
Schuenemann, H. J. .
ALLERGY, 2009, 64 (08) :1109-1116
[9]   Grading quality of evidence and strength of recommendations in clinical practice guidelines [J].
Brozek, J. L. ;
Akl, E. A. ;
Alonso-Coello, P. ;
Lang, D. ;
Jaeschke, R. ;
Williams, J. W. ;
Phillips, B. ;
Lelgemann, M. ;
Lethaby, A. ;
Bousquet, J. ;
Guyatt, G. H. ;
Schuenemann, H. J. .
ALLERGY, 2009, 64 (05) :669-677
[10]   Diagnosis and treatment of low back pain: A joint clinical practice guideline from the American college of physicians and the American pain society [J].
Chou, Roger ;
Qaseem, Amir ;
Snow, Vincenza ;
Casey, Donald ;
Cross, J. Thomas, Jr. ;
Shekelle, Paul ;
Owens, Douglas K. .
ANNALS OF INTERNAL MEDICINE, 2007, 147 (07) :478-491